These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27134253)

  • 1. Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus.
    Zhao L; Xu D; Qiao L; Zhang X
    J Rheumatol; 2016 Jun; 43(6):1038-44. PubMed ID: 27134253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Marrow megakaryocyte count as a response predictor of severe thrombocytopenia in patients with primary Sjögren syndrome].
    Xue Y; Xu D; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):282-287. PubMed ID: 30917421
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of bone marrow megakaryocyte count for immunotherapeutic response in primary Sjögren's syndrome patients with severe immune thrombocytopenia: A single-center case-control study in China.
    Zhong H; Xue Y; Zhang L; Yang Y; Zhou J; Zhang S; Jiang N; Qiao L; Peng L; Wang L; Zhang W; Xu D; Li M; Zhao Y; Zeng X
    Int J Rheum Dis; 2023 Jul; 26(7):1260-1267. PubMed ID: 37183556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspects in the tale of lupus-associated thrombocytopenia.
    Ziakas PD; Routsias JG; Giannouli S; Tasidou A; Tzioufas AG; Voulgarelis M
    Clin Exp Immunol; 2006 Jul; 145(1):71-80. PubMed ID: 16792676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.
    Üsküdar Cansu D; Üsküdar Teke H; Işiksoy S; Korkmaz C
    Int J Rheum Dis; 2018 May; 21(5):1049-1059. PubMed ID: 29671953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immature platelet levels correlate with disease activity and predict treatment response of thrombocytopenia in lupus patients.
    Hanata N; Shoda H; Kono M; Komai T; Natsumoto B; Tsuchida Y; Tsuchiya H; Nagafuchi Y; Taoka K; Kurokawa M; Fujio K
    Lupus; 2021 Oct; 30(11):1764-1772. PubMed ID: 34304626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
    Kuwana M; Okazaki Y; Kajihara M; Kaburaki J; Miyazaki H; Kawakami Y; Ikeda Y
    Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible bone marrow dysplasia in patients with systemic lupus erythematosus.
    Oka Y; Kameoka J; Hirabayashi Y; Takahashi R; Ishii T; Sasaki T; Harigae H
    Intern Med; 2008; 47(8):737-42. PubMed ID: 18421190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
    Arnal C; Piette JC; Léone J; Taillan B; Hachulla E; Roudot-Thoraval F; Papo T; Schaeffer A; Bierling P; Godeau B
    J Rheumatol; 2002 Jan; 29(1):75-83. PubMed ID: 11824975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Fukushima T; Dong L; Sakai T; Sawaki T; Miki M; Tanaka M; Masaki Y; Hirose Y; Kuwana M; Umehara H
    Lupus; 2008 Mar; 17(3):210-4. PubMed ID: 18372362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.
    Kuwana M; Kaburaki J; Okazaki Y; Miyazaki H; Ikeda Y
    Rheumatology (Oxford); 2006 Jul; 45(7):851-4. PubMed ID: 16418192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia after bone marrow transplantation for leukaemia: changes in megakaryocyte growth and growth-promoting activity.
    Adams JA; Gordon AA; Jiang YZ; Macdonald D; McCarthy DM; Zuiable A; Treleaven J; Powles RL; Barrett AJ
    Br J Haematol; 1990 Jun; 75(2):195-201. PubMed ID: 2372505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired amegakaryocytic thrombocytopenia: three case reports and a literature review].
    Antonijević N; Terzić T; Jovanović V; Suvajdzić N; Milosević R; Basara N; Elezović I
    Med Pregl; 2004; 57(5-6):292-7. PubMed ID: 15503803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases.
    Blanco R; Martinez-Taboada VM; Rodriguez-Valverde V; Sanchez-Andrade A; González-Gay MA
    Br J Rheumatol; 1997 Oct; 36(10):1095-9. PubMed ID: 9374927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.
    You YN; Tefferi A; Nagorney DM
    Ann Surg; 2004 Aug; 240(2):286-92. PubMed ID: 15273553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A morphometric study of bone marrow megakaryocytes in foals infected with equine infectious anemia virus.
    Wardrop KJ; Baszler TV; Reilich E; Crawford TB
    Vet Pathol; 1996 Mar; 33(2):222-7. PubMed ID: 8801716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study.
    Li J; Peng L; Wu L; Ding Y; Duan X; Xu J; Wei W; Chen Z; Zhao C; Yang M; Jiang N; Zhang S; Wang Q; Tian X; Li M; Zeng X; Zhao Y; Zhao J
    Arthritis Res Ther; 2024 Mar; 26(1):67. PubMed ID: 38475924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An autopsy case of systemic lupus erythematosus complicating leukocytosis, amegakaryocytic thrombocytopenia, interstitial pneumonitis, and pleulitis].
    Kawamoto A; Shiiki H; Hanatani M; Hashimoto T; Dohi K
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Jun; 19(3):223-31. PubMed ID: 8810548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B; Lindholm C; Pullerits R
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.